Cite

HARVARD Citation

    Pantano, F. et al. (2020). Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab. Expert opinion on biological therapy. pp. 319-326. [Online]. 
  
Back to record